MAM
InMobi launches in-game advertising for global brands and agencies
NEW DELHI: With more and more Indians turning to mobile gaming to chase away the pandemic blues, the mode of self-entertainment now offers a plethora of opportunities for brands to connect with their TG. With this insight, mobile advertising platform InMobi has launched in-game advertising on InMobi Exchange. This will enable brands to reach premium mobile users, with ads that blend into the game environment, like electronic advertising boards in an in-game sports stadium, an e-sports arena or the extremely popular casual and hyper-casual gaming space.
InMobi India VP & general manager Jayesh Ullattil said, “India is the 5th largest mobile gaming market in the world. Based on our recent consumer study, we saw that the pandemic added 40 per cent first-time gamers with 80 per cent of all mobile gamers playing once or several times every day. 74 per cent of all mobile gamers prefer to watch an ad over making in-app purchases and 60 per cent recall the ad seen during play. This innovative partnership only enables advertisers to further maximise engagement with an already watchful and engaged audience.”
InMobi Exchange has partnerships with several platforms in the native in-game advertising space including AdInMo, Admix, Adverty, Anzu, Bidstack, Frameplay and Sayollo. This means that advertisers can access this premium inventory across the globe at a scale and diversity unmatched by any other mobile supply-side platform today, the company said in a press statement.
“In-game advertising is uniquely effective because it allows advertisers to interact with their consumers in a highly intuitive way,” said InMobi SVP & general manager – publisher platforms and exchange Kunal Nagpal.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
